Preputial Adhesiolysis Management

First-Line Medical Management

The American College of Physicians recommends topical corticosteroid therapy as the first-line treatment for preputial adhesions, achieving success rates of 75-84% and avoiding surgical intervention in the majority of cases 1
Topical corticosteroid therapy is effective in treating preputial adhesions, with a success rate of 84% in pediatric patients 1, 2

For pediatric patients with preputial adhesions, apply betamethasone 0.05% ointment to the adhesion site twice daily for 4-6 weeks 1, 2
If improving but not fully resolved after initial 4-6 weeks, continue treatment for additional 2-4 weeks 1, 2
For adult patients with preputial adhesions or phimosis, apply clobetasol propionate 0.05% ointment once daily for 1-3 months 1

If no improvement after 4-6 weeks of appropriate topical steroid therapy, consider more intensive steroid regimen if lichen sclerosus is suspected 1, 2
Refer for surgical adhesiolysis or circumcision if there is no improvement after 4-6 weeks of topical steroid therapy 1, 2

Repeat the course of topical steroid treatment for 1-3 months for recurrent adhesions 1
Most patients with ongoing issues require 30-60g of clobetasol propionate 0.05% ointment annually for maintenance 1

Long-term use of clobetasol propionate in appropriate doses has been shown to be safe without evidence of significant steroid damage 1
Instruct patients on aggressive hand washing after steroid application to avoid spreading medication to sensitive areas (eyes, mouth) 3
Advise patients to avoid partner exposure 3

Many patients are referred for circumcision without an adequate trial of topical steroids—always attempt medical management first 1, 2
Failure to recognize lichen sclerosus as underlying cause leads to treatment failure and unnecessary repeated interventions 1, 2

Limiting topical corticosteroid application to the preputial ring minimizes total steroid absorption, reducing systemic absorption and potential side effects, as noted by the British Journal of Dermatology 4, 5
The British Journal of Dermatology recommends targeted application of clobetasol propionate to prevent unnecessary skin atrophy, with long-term use shown to be safe when used appropriately 4, 5
Accurate placement of topical steroid at the site of pathology can be achieved using a cotton wool bud, allowing targeted delivery even when the opening is very narrow, as suggested by the British Journal of Dermatology 6